Role for 18:1 Lysophosphatidic Acid as an Autocrine Mediator in Prostate Cancer Cells
Open Access
- 1 September 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (36) , 32516-32526
- https://doi.org/10.1074/jbc.m203864200
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Acyl and Alkyl Ether-Linked Lysophosphatidic Acids in the Nervous SystemAnnals of the New York Academy of Sciences, 2006
- ESSENTIAL ROLE FOR G PROTEINS IN PROSTATE CANCER CELL GROWTH AND SIGNALINGJournal of Urology, 2000
- Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA speciesFEBS Letters, 2000
- LPA as a Paracrine Mediator of Adipocyte Growth and FunctionAnnals of the New York Academy of Sciences, 2000
- Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancersThe Prostate, 2000
- Expression and regulation of phospholipase D isoforms in mammalian cell linesJournal of Cellular Physiology, 1999
- cDNA Cloning and Expression of Murine 1-Acyl-sn-glycerol-3-phosphate AcyltransferaseBiochemical and Biophysical Research Communications, 1997
- Amyloid beta protein (25–35) stimulation of phospholipases A, C and D activities of LA‐N‐2 cellsFEBS Letters, 1995
- Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Human platelet aggregation induced by 1-alkyl-lysophosphatidic acid and its analogs: A new group of phospholipid mediators?Biochemical and Biophysical Research Communications, 1982